Although losartan, an angiotensin II receptor blocker could have acted as a trigger for the angioedema episode in a predisposed individual, as described for ACE-inhibitors by Kleiner et al. [15], and angioedema due to angiotensin II receptor blockers typically affects the tongue, it is extremely rare. The gene discussed is ACE; the disease is angioedema.